Task: Answer the multiple choice question.
Question: Which drug exhibits a -1.735\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1ccc(/C=N/n2cnc3sc(-c4ccccc4)cc3c2=O)o1
b: COc1ccc(OC)c(NC(=O)CCS(=O)(=O)c2cc3c(cc2C)NC(=O)CO3)c1
c: Cc1ccc(C(=O)NC(C)(COc2nonc2C)COc2nonc2C)cc1
Answer: c. Cc1ccc(C(=O)NC(C)(COc2nonc2C)COc2nonc2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)NC(C)(COc2nonc2C)COc2nonc2C)cc1
Cc1ccc(C(=O)NC(C)(COc2nonc2C)COc2nonc2C)cc1
4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide